Medication info
Telmisartan and Hydrochlorothiazide Tablets 80/12.5 mg

Telmisartan and Hydrochlorothiazide Tablets 80/12.5 mg

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›80mg / 1 tabletHydrochlorothiazide›12.5mg / 1 tablet
Manufacturer / importer
Hanpoong Pharmaceutical Co., Ltd.
Appearance
White or off-white rectangular tablets
Packaging
30 tablets/box [(10 tablets/Alu-Alu) x 3]
Approval status
Active

MFDS item code 201906586 · Approved 2019.09.20 · Insurance code 658107580

Summary

Main use
Treatment of essential hypertension not controlled with telmisartan alone
Who takes it
Adults · Children
Adult dose
Adults For patients whose blood pressure is not adequately controlled with telmisartan monotherapy, take once daily with a beverage, with or without food. Before switching to this fixed-dose combination, it is recommended that the doses of each component be individually adjusted and administered separately. When clinically appropriate, direct switching from monotherapy to this medicine may also be considered. - The telmisartan/hydrochlorothiazide combination 40/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 40mg. - The telmisartan/hydrochlorothiazide combination 80/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg. - The telmisartan/hydrochlorothiazide combination 80/25mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg and hydrochlorothiazide 12.5mg given as separate products or as a combination product. Sodium or volume depletion should be corrected before starting this medicine. Patients with renal impairment No dose adjustment is required in patients with mild to moderate renal impairment. Do not administer this medicine to patients with severe renal impairment (creatinine clearance<30mL/min). Periodic monitoring of renal function is recommended. Patients with hepatic impairment This medicine should be administered with caution to patients with mild to moderate hepatic impairment. Do not administer this medicine at a dose exceeding 40/12.5mg once daily. This medicine should not be administered to patients with severe hepatic impairment (see Precautions for Use, 2). Thiazide diuretics should be administered with caution to patients with impaired hepatic function. Older adults No dose adjustment is required.
Child dose
The safety and efficacy of this medicine have not been established in children under 18 years of age.

Ingredients

Manufacturer
Hanpoong Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with telmisartan alone

  • Essential hypertension
View approved original text

This medication is used for the treatment of essential hypertension. It is particularly administered as an adjunct treatment for patients whose blood pressure is not adequately controlled by telmisartan alone. This helps effectively lower blood pressure and aids in managing hypertension.

How to take

Adult dose

Adults For patients whose blood pressure is not adequately controlled with telmisartan monotherapy, take once daily with a beverage, with or without food. Before switching to this fixed-dose combination, it is recommended that the doses of each component be individually adjusted and administered separately. When clinically appropriate, direct switching from monotherapy to this medicine may also be considered. - The telmisartan/hydrochlorothiazide combination 40/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 40mg. - The telmisartan/hydrochlorothiazide combination 80/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg. - The telmisartan/hydrochlorothiazide combination 80/25mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg and hydrochlorothiazide 12.5mg given as separate products or as a combination product. Sodium or volume depletion should be corrected before starting this medicine. Patients with renal impairment No dose adjustment is required in patients with mild to moderate renal impairment. Do not administer this medicine to patients with severe renal impairment (creatinine clearance<30mL/min). Periodic monitoring of renal function is recommended. Patients with hepatic impairment This medicine should be administered with caution to patients with mild to moderate hepatic impairment. Do not administer this medicine at a dose exceeding 40/12.5mg once daily. This medicine should not be administered to patients with severe hepatic impairment (see Precautions for Use, 2). Thiazide diuretics should be administered with caution to patients with impaired hepatic function. Older adults No dose adjustment is required.

Child dose

The safety and efficacy of this medicine have not been established in children under 18 years of age.

Precautions

This medication should not be used during pregnancy, especially in the second and third trimesters, as it can have serious effects on the fetus. If pregnancy is confirmed, the medication should be discontinued as soon as possible, and if necessary, replaced with another safe medication. Patients who are allergic to any components of this medication or have certain liver or kidney diseases should not take it. Elderly patients or those with high potassium levels in the blood or impaired liver function should exercise caution when using this medication. The hydrochlorothiazide component can affect electrolyte balance in the body, so electrolyte levels should be regularly checked through blood tests during usage. While taking this medication, dizziness, hypotension, or muscle cramps may occur, so caution is advised, and if symptoms are severe, consultation with healthcare professionals is needed. Additionally, the hydrochlorothiazide component may cause sensitivity to sunlight, so it is important to pay attention to UV protection during treatment. There may be interactions with other medications, so if other drugs are being taken, be sure to inform healthcare professionals. In case of overdose, symptoms such as hypotension or electrolyte imbalance may occur, and one should visit a medical facility immediately for proper treatment. This medication is not recommended for children under 18 years, as its safety and effectiveness have not been established. After taking the medication, caution is needed for driving or operating machinery as dizziness or drowsiness may occur. Finally, this medication should be kept out of the reach of children and used immediately after taking it out of its packaging.

Side effects

Hypotension, neonatal craniosynostosis, anuria, renal failure, oligohydramnios, limb spasms, craniofacial malformations, hypoplasia of the lungs, prematurity, intrauterine growth retardation, patent ductus arteriosus, bronchitis, pharyngitis, sinusitis, hypokalemia, hyperuricemia, hyponatremia, anxiety, depression, insomnia, sleep disturbances, dizziness, syncope, paresthesia, visual impairment, blurred vision, vertigo, tachycardia, arrhythmia, hypotension, orthostatic hypotension, dyspnea, respiratory distress, pneumonia, pulmonary edema, diarrhea, dry mouth, distention, abdominal pain, constipation, dyspepsia, vomiting, gastritis, liver function abnormality, liver disorder, angioedema, erythema, pruritus, rash, hyperhidrosis, urticaria, back pain, muscle spasm, myalgia, arthralgia, limb pain, systemic lupus erythematosus, erectile dysfunction, chest pain, influenza-like illness, pain, increased uric acid in blood, increased creatinine in blood, increased creatine phosphokinase activity in blood, increased liver enzymes, upper respiratory infection, urinary tract infection, cystitis, sepsis, anemia, eosinophilia, thrombocytopenia, anaphylactic reaction, hyperkalemia, hypoglycemia, drowsiness, bradycardia, cough, interstitial lung disease, dry mouth, abdominal discomfort, dysgeusia, eczema, drug rash, toxic skin rash, pain in the bones, kidney dysfunction, asthenia, influenza-like illness, increased creatinine in blood, decreased hemoglobin, sialadenitis, non-melanoma skin cancer, thrombocytopenic purpura, hemolytic anemia, bone marrow failure, leukopenia, agranulocytosis, hypersensitivity, aplastic anemia, hyperlipidemia, decreased appetite, hypomagnesemia, hyperglycemia, hypercalcemia, hypochloremic metabolic alkalosis, headache, yellow vision, acute myopia, acute angle closure glaucoma, choroidal exudation, necrotizing vasculitis, acute respiratory distress syndrome, nausea, pancreatitis, jaundice, cholestasis, photosensitivity reaction, toxic epidermal necrolysis, lupus-like syndrome, systemic lupus erythematosus, acute renal failure, diabetes, asthenia, fever, nausea, gastrointestinal hemorrhage, esophagitis, headache, tremors, facial flushing, malaise, fatigue, weight loss, proteinuria, itching, myalgia, floating sensation, tremors of lips and hands, hypersensitivity, decrease in vision, hypoglycemia, intestinal vascular edema

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it should be stored in a tightly closed container. It is recommended to maintain the storage temperature between 1 degree and 30 degrees Celsius at room temperature. This will help preserve the medication's effectiveness for a longer period.

Appearance and packaging

Appearance

White or off-white rectangular tablets

Package unit

30 tablets/box [(10 tablets/Alu-Alu) x 3]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.